Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02
Published February 9, 2022 · Recall initiated: January 10, 2022
Summary
FDA records drug Class II recall D-0520-2022, published February 9, 2022 and initiated January 10, 2022. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 1,175 Bottles; Lot: Lot #: 100022970, Exp. 08/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- nationwide in the USA
- Lot
- Lot #: 100022970, Exp. 08/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, RxFebruary 9, 2022
- FDADoxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, RxFebruary 9, 2022
- FDAMimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, RxFebruary 9, 2022
- FDASinus Relief Headache/Nasal (acetaminophen 325mg, phenylephrine HCl 5mg), 2 tablet packets, Manufactured forFebruary 9, 2022
- FDASinus Relief (acetaminophen 325mg, Guaifenesin 200mg, phenylephrine HCl 5mg), 2-tablet packets, ManufacturedFebruary 9, 2022
- FDABrinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottles (NDC 0591-2127-79), and b) 15January 26, 2022
Questions about this recall
Was Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02 recalled?
Yes. FDA published recall D-0520-2022 on February 9, 2022. Reported hazard: Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter